Noah James Sugden
Examiner (ID: 11083)
Most Active Art Unit | 4137 |
Art Unit(s) | 4137 |
Total Applications | 5 |
Issued Applications | 0 |
Pending Applications | 5 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
10/909590 | Natural pharmaceutical composition for treatment of human and animal cancers | Aug 1, 2004 | Abandoned |
Array
(
[id] => 7319355
[patent_doc_number] => 20040225020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Methods and compositions for aiding in smoking cessation and for treating pain and other disorders using optically pure (-) -bupropion'
[patent_app_type] => new
[patent_app_number] => 10/848069
[patent_app_country] => US
[patent_app_date] => 2004-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7163
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20040225020.pdf
[firstpage_image] =>[orig_patent_app_number] => 10848069
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/848069 | Methods and compositions for aiding in smoking cessation and for treating pain and other disorders using optically pure (-) -bupropion | May 18, 2004 | Abandoned |
Array
(
[id] => 7347675
[patent_doc_number] => 20040192783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Use of B-2 bronchodilator drugs'
[patent_app_type] => new
[patent_app_number] => 10/821553
[patent_app_country] => US
[patent_app_date] => 2004-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6803
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20040192783.pdf
[firstpage_image] =>[orig_patent_app_number] => 10821553
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/821553 | Use of B-2 bronchodilator drugs | Apr 8, 2004 | Abandoned |
Array
(
[id] => 7436511
[patent_doc_number] => 20040266882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Aryloxypropylamines as chemosensitizing agents in the treatment of cancer'
[patent_app_type] => new
[patent_app_number] => 10/488095
[patent_app_country] => US
[patent_app_date] => 2004-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14134
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20040266882.pdf
[firstpage_image] =>[orig_patent_app_number] => 10488095
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/488095 | Aryloxypropylamines as chemosensitizing agents in the treatment of cancer | Mar 7, 2004 | Abandoned |
Array
(
[id] => 758231
[patent_doc_number] => 07015244
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-03-21
[patent_title] => 'Inhalable chemical debridement for COPD'
[patent_app_type] => utility
[patent_app_number] => 10/696863
[patent_app_country] => US
[patent_app_date] => 2003-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 6582
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/015/07015244.pdf
[firstpage_image] =>[orig_patent_app_number] => 10696863
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/696863 | Inhalable chemical debridement for COPD | Oct 29, 2003 | Issued |
Array
(
[id] => 761199
[patent_doc_number] => 07012091
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-03-14
[patent_title] => 'Inhalable inhibitors of inflammation in the respiratory tract'
[patent_app_type] => utility
[patent_app_number] => 10/694236
[patent_app_country] => US
[patent_app_date] => 2003-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 5302
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/012/07012091.pdf
[firstpage_image] =>[orig_patent_app_number] => 10694236
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/694236 | Inhalable inhibitors of inflammation in the respiratory tract | Oct 24, 2003 | Issued |
Array
(
[id] => 7674579
[patent_doc_number] => 20040127539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Antiangiogenic combination therapy for the treatment of cancer'
[patent_app_type] => new
[patent_app_number] => 10/692643
[patent_app_country] => US
[patent_app_date] => 2003-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53589
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20040127539.pdf
[firstpage_image] =>[orig_patent_app_number] => 10692643
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/692643 | Antiangiogenic combination therapy for the treatment of cancer | Oct 23, 2003 | Abandoned |
Array
(
[id] => 7188354
[patent_doc_number] => 20050192299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Method of treating or preventing hepatitis B virus'
[patent_app_type] => utility
[patent_app_number] => 10/656889
[patent_app_country] => US
[patent_app_date] => 2003-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 14930
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20050192299.pdf
[firstpage_image] =>[orig_patent_app_number] => 10656889
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/656889 | Method of treating or preventing hepatitis B virus | Sep 3, 2003 | Abandoned |
Array
(
[id] => 769413
[patent_doc_number] => 07005447
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-02-28
[patent_title] => 'Food product comprising hydroxymatairesinol'
[patent_app_type] => utility
[patent_app_number] => 10/639530
[patent_app_country] => US
[patent_app_date] => 2003-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7581
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/005/07005447.pdf
[firstpage_image] =>[orig_patent_app_number] => 10639530
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/639530 | Food product comprising hydroxymatairesinol | Aug 12, 2003 | Issued |
Array
(
[id] => 7368298
[patent_doc_number] => 20040092565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Composition and method of sustaining chemotherapeutic effect while reducing dose of chemotherapeutic agent using cox-2 inhibitor and statin'
[patent_app_type] => new
[patent_app_number] => 10/470032
[patent_app_country] => US
[patent_app_date] => 2003-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20196
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20040092565.pdf
[firstpage_image] =>[orig_patent_app_number] => 10470032
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/470032 | Composition and method of sustaining chemotherapeutic effect while reducing dose of chemotherapeutic agent using cox-2 inhibitor and statin | Jul 21, 2003 | Abandoned |
Array
(
[id] => 782862
[patent_doc_number] => 06992110
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-01-31
[patent_title] => 'Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain'
[patent_app_type] => utility
[patent_app_number] => 10/623378
[patent_app_country] => US
[patent_app_date] => 2003-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7400
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/992/06992110.pdf
[firstpage_image] =>[orig_patent_app_number] => 10623378
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/623378 | Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain | Jul 17, 2003 | Issued |
Array
(
[id] => 968605
[patent_doc_number] => 06939879
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-06
[patent_title] => 'Use of R (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of substance induced insomnia'
[patent_app_type] => utility
[patent_app_number] => 10/609751
[patent_app_country] => US
[patent_app_date] => 2003-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6412
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/939/06939879.pdf
[firstpage_image] =>[orig_patent_app_number] => 10609751
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/609751 | Use of R (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of substance induced insomnia | Jun 29, 2003 | Issued |
10/311203 | Nutrient formulations for reduction and related treatment and component screening methods | Jun 12, 2003 | Abandoned |
Array
(
[id] => 7314614
[patent_doc_number] => 20040034060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'Pharmacologic inhibition of Myc function'
[patent_app_type] => new
[patent_app_number] => 10/459769
[patent_app_country] => US
[patent_app_date] => 2003-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9512
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20040034060.pdf
[firstpage_image] =>[orig_patent_app_number] => 10459769
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/459769 | Pharmacologic inhibition of Myc function | Jun 11, 2003 | Issued |
Array
(
[id] => 745302
[patent_doc_number] => 07026353
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-11
[patent_title] => 'Inhibition of Gram positive bacteria'
[patent_app_type] => utility
[patent_app_number] => 10/434193
[patent_app_country] => US
[patent_app_date] => 2003-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 3479
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/026/07026353.pdf
[firstpage_image] =>[orig_patent_app_number] => 10434193
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/434193 | Inhibition of Gram positive bacteria | May 8, 2003 | Issued |
Array
(
[id] => 6664598
[patent_doc_number] => 20030203924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-30
[patent_title] => 'Novel combination of benzoquinazoline antifolates and protecting agents'
[patent_app_type] => new
[patent_app_number] => 10/431016
[patent_app_country] => US
[patent_app_date] => 2003-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7596
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20030203924.pdf
[firstpage_image] =>[orig_patent_app_number] => 10431016
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/431016 | Combination of benzoquinazoline antifolates and protecting agents | May 6, 2003 | Issued |
Array
(
[id] => 7474133
[patent_doc_number] => 20040122011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-24
[patent_title] => 'Method of using a COX-2 inhibitor and a TACE inhibitors as a combination therapy'
[patent_app_type] => new
[patent_app_number] => 10/423526
[patent_app_country] => US
[patent_app_date] => 2003-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72000
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20040122011.pdf
[firstpage_image] =>[orig_patent_app_number] => 10423526
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/423526 | Method of using a COX-2 inhibitor and a TACE inhibitors as a combination therapy | Apr 24, 2003 | Abandoned |
Array
(
[id] => 6664550
[patent_doc_number] => 20030203876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-30
[patent_title] => 'Organic compounds'
[patent_app_type] => new
[patent_app_number] => 10/410376
[patent_app_country] => US
[patent_app_date] => 2003-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6470
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20030203876.pdf
[firstpage_image] =>[orig_patent_app_number] => 10410376
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/410376 | Organic compounds | Apr 8, 2003 | Abandoned |
Array
(
[id] => 6770518
[patent_doc_number] => 20030216458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Combination therapy for the treatment of migraine'
[patent_app_type] => new
[patent_app_number] => 10/410664
[patent_app_country] => US
[patent_app_date] => 2003-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5893
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20030216458.pdf
[firstpage_image] =>[orig_patent_app_number] => 10410664
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/410664 | Combination therapy for the treatment of migraine | Apr 8, 2003 | Abandoned |
Array
(
[id] => 6865657
[patent_doc_number] => 20030191183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Method for e3nhanced delivery of oxybutynin and compositions thereof'
[patent_app_type] => new
[patent_app_number] => 10/403653
[patent_app_country] => US
[patent_app_date] => 2003-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4852
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20030191183.pdf
[firstpage_image] =>[orig_patent_app_number] => 10403653
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/403653 | Method for e3nhanced delivery of oxybutynin and compositions thereof | Mar 30, 2003 | Abandoned |